腹水的诊断与评估

doi:10.3969/j.issn.1672-5069.2018.05.002

Abstract

Liang Jing, Han Tao.. Highlights of diagnosis and evaluation of ascites[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 661-664.

[1] Runyon BA.Management of adult patients with ascites due to cirrhosis. Hepatology,2004,39(3):841-856.
[2] Hanbidge AE,Lynch D,Wilson SR. US of the peritoneum. Radiographics:a review publication of the Radiological Society of North America,Inc,2003,23(3):663-684,discussion 84-85.
[3] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 临床肝胆病杂志,2017,34(10):1847-1863.
[4] Hou W,Sanyal AJ.Ascites:diagnosis and management. Med Clin North Am,2009,93(4):801-817.
[5] Moore CM,van Thiel DH. Cirrhotic ascites review: Pathophysiology,diagnosis and management. World J Hepatol,2013,5(5):251-263.
[6] Runyon BA,Montano AA,Akriviadis EA,et al.The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med,1992,117(3):215-220.
[7] Arroyo V,Terra C,Gines P.Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol,2007,46(5):935-946.
[8] Becker G,Galandi D,Blum HE.Malignant ascites:systematic review and guideline for treatment. Eur J Cancer,2006,42(5):589-597.
[9] Bes DF,Feernandez MC,Malla I,et al.Management of cirrhotic ascites in children. Review and recommendations. Part 1: Pathophysiology,diagnostic evaluation,hospitalization criteria,treatment,nutritional management. Arch Argentinos de Pediatria, 2017,115(4):385-390.
[10] Fan CQ,Crawford JM.Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Experiment Hepatol,2014,4(4):332-346.
[11] Paik JY,Kim KW,Kwon HJ,et al.Peritoneal mesotheliomas:clinicopathologic features,CT findings,and differential diagnosis. AJR,2008,191(3):814-825.
[12] Cuko L,Bilaj F,Bega B, et al.Eosinophilic ascites,as a rare presentation of eosinophilic gastroenteritis. Hippokratia,2014,18(3):275-277.
[13] Peeters P,Cpiie II,Sennesael J,et al.Relapsing ascites and uremia due to urinary bladder leakage. Eur J Intern Med,2001,12(1):60-63.
[14] Runyon BA,Hoefs JC,Morgan TR.Ascitic fluid analysis in malignancy-related ascites. Hepatology,1988,8(5):1104-1109.
[15] Bhardwaj R,Vaziri H,Gautam A,et al.Chylous ascites:A review of pathogenesis,diagnosis and treatment. J Clin Translat Hepatol,2018,6(1):105-113.
[16] Lizaola B,Bonder A,Trivedi HD,et al.Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Therapeut,2017,46(9):816-824.
[17] Larsen M,Kozarek R.Management of pancreatic ductal leaks and fistulae. J Gastroenterol Hepatol,2014,29(7):1360-1370.
[18] Limeme M,Yahyaoui S,Zaghouani H,et al.Spontaneous intraperitoneal rupture of hepatic hydatid cyst:a rare cause of ascites. BMC Surg,2014,14(99):1239-1243.
[19] Younas M,Sattar A,Hashim R,et al.Role of serum-ascites albumin gradient in differential diagnosis of ascites. JAMC,2012,24(3-4):97-99.
[20] Hoefs JC.Globulin correction of the albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradients. Hepatology,1992,16(2):396-403.
[21] Bavdekar A,Thakur N.Ascites in children. Indian J Pediat,2016,83(11):1334-1340.
[22] 宿远东. SAAG联合腹水总蛋白水平诊断肝硬化腹水的意义 . 胃肠病学和肝病学杂志,2011,20(1):53-54.
[23] Verma A,Abisheganaden J,Light RW.Identifying malignant pleural effusion by a cancer ratio(serum LDH:pleural fluid ADA ratio). Lung,2016,194(1):147-153.
[24] Sevinc A,Sari R,Fadillioglu E.The utility of lactate dehydrogenase isoenzyme pattern in the diagnostic evaluation of malignant and nonmalignant ascites. J Nat Med Ass,2005,97(1): 79-84.
[25] Huang LL,Xia HH,Zhu SL.Ascitic fluid analysis in the differential diagnosis of ascites:Focus on cirrhotic ascites. J Clin Translat Hepatol,2014,2(1):58-64.
[26] Gokturk HS,Demir M,Ozturk NA,et al.The role of ascitic fluid viscosity in the differential diagnosis of ascites. Ca J Gastroenterol,2010,24(4):255-259.
[27] Liao YJ,Wu CY,Lee SW,et al.Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol 2012,18(37):5260-5265.
[28] Tao L,Ning HJ,Nie HM,et al.Diagnostic value of adenosine deaminase in ascites for tuberculosis ascites:a meta-analysis. Diagnost Microbiol Infect Dis,2014,79(1):102-107.
[29] Runyon BA.Amylase levels in ascitic fluid. J Clin Gastroenterol,1987,9(2):172-174.
[30] Satz N,Ammann R.Pancreatogenic ascites. Schweizerische Medizinische Wochenschrift,1978,108(26):980-988.
[31] Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club. Hepatology,2003,38(1):258-266.
[32] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol,2018[ahead of print].
[33] EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis. J Hepatol,2010,53(3):397-417.
[34] Tan MF,Ng WC,Chan SH,et al.Comparative usefulness of PCR in the detection of mycobacterium tuberculosis in different clinical specimens. J Med Microbiol,1997,46(2):164-169.
[35] Portillo-Gomez L,Morris SL,Panduro A.Rapid and efficient detection of extra-pulmonary Mycobacterium tuberculosis by PCR analysis. Int J Tubercul Lung Dis,2000,4(4):361-370.
[36] Soriano G,Esparcia O,Montemayor M,et al.Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis. Aliment Pharmacol Therapeut,2011,33(2):275-284.
[37] Lahmer T,Brandl A,Rasch S,et al.Fungal peritonitis: Underestimated disease in critically Ill patients with liver cirrhosis and spontaneous peritonitis. PloS one,2016,11(7):e0158389.
[38] Fiore M,Leone S.Spontaneous fungal peritonitis:Epidemiology,current evidence and future prospective. World J Gastroenterol,2016,22(34):7742-7747.
[39] Liu F,Kong X,Dou Q,et al.Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Ann Hepatol,2014,13(3):357-363.
[40] Manenti L,Riccardi E,Marchini S,et al.Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy. Mol Cancer Therapeuti,2005,4(5):715-725.
[41] Abdel-Razik A,Mousa N,Elalfy H,et al.A novel combination of C-reactive protein and vascular endothelial growth factor in differential diagnosis of ascites. J Gastrointest Cancer,2017,48(1):50-57.
[42] Gravito-Soares M,Gravito-Soares E,Almeida J,et al.Challenging and uncommon diagnosis of long-evolution ascites. BMJ Case Rep,2017,35(4):231-236.

Highlights of diagnosis and evaluation of ascites

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Ding Limin, Wang Fei, Piao Lianshu, et al.. Etiology of 202 patients with abnormal liver function tests [J]. Journal of Practical Hepatology, 2019, 22(6): 856-859.
[4]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[5]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[12]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[13]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[14]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[15]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.